Φορτώνει......

Predictive factors for outcome and response in patients treated with second-generation tyrosine kinase inhibitors for chronic myeloid leukemia in chronic phase after imatinib failure

We assessed the predictive factors for outcome and response in 123 patients with chronic myeloid leukemia in chronic phase treated with second-generation tyrosine kinase inhibitors (TKIs) after imatinib failure. Better event-free survival rates with second-generation TKI therapy were associated with...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς: Jabbour, Elias, Kantarjian, Hagop, O'Brien, Susan, Shan, Jenny, Garcia-Manero, Guillermo, Wierda, William, Ravandi, Farhad, Borthakur, Gautam, Rios, Mary Beth, Cortes, Jorge
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: American Society of Hematology 2011
Θέματα:
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4081281/
https://ncbi.nlm.nih.gov/pubmed/21030554
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2010-07-293977
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!